Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

merckincweb

Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer

September 22, 2020 Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma

MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …
News
shutterstock_38078521

New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda

New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …
News
shutterstock_159488225

Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma

New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …
News
libtayo

Promising Phase 2 data for Sanofi and Regeneron’s PD-1 inhibitor Libtayo in locally advanced basal cell carcinoma

September 18, 2020 Medical Communications, Research and Development Cancer, ESMO 2020, Libtayo, Regeneron, Sanofi, pharma

Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …
News
256px-mikhail_murashko_2020-01-29

One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020 Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
News
novartis_outside_1

Novartis’ Tafinlar/Mekinist combo improves five-year relapse-free survival in new Phase 3 data

September 17, 2020 Research and Development Novartis, Tafinlar, mekinist, melanoma

Novartis has unveiled promising new Phase 3 data for its combination of Tafinlar (dabrafenib) with Mekinist (trametinib) in the treatment …
News
800px-vaccine_image_1

Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccine

September 17, 2020 Research and Development coronavirus vaccines, vaccines

The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …
News
donald_trump_29496131773

US sets out plans to distribute free coronavirus vaccines

September 17, 2020 Research and Development

The Trump administration has laid out its strategy to distribute COVID-19 vaccines for free across the US.  The Department of …
News
alex_azar_-_pete_marovich-getty_images

HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews

September 16, 2020 Research and Development COVID-19, FDA, US, USA

Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …
News
gettyimages-1206570416

India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020 Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …
News
800px-pfizer_finland_hq_february_13_2009

Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study

September 16, 2020 Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …
News
steve_bannon_32289717844

Study that alleges COVID-19 was made in a Chinese lab originated from non-profits linked to ex-Trump advisor Steve Bannon

September 16, 2020 Research and Development China, Donald Trump, Steve Bannon, Wuhan, coronavirus

A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 16, 2020 Research and Development COVID, COVID-19 vaccine, coronavirus

The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for itsmuch-hyped vaccine were halted after an …
News
lilly_building_with_american_flag_web

Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data

September 15, 2020 Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir

Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …
News
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026